Relevant bibliographies by topics / BPH- Benign prostatic hyperplasia

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'BPH- Benign prostatic hyperplasia'

Author: Grafiati
Published: 5 June 2025
Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'BPH- Benign prostatic hyperplasia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "BPH- Benign prostatic hyperplasia"

1

Ipnamelti, Ipnamelti, Bayhakki Bayhakki, and Yesi Hasneli N. "Hubungan Lower Urinary Tract Symptoms (LUTS) dengan Kualitas Hidup Pasien Benigna Prostatic Hyperplasia (BPH)." Malahayati Nursing Journal 7, no. 1 (2025): 222–36. https://doi.org/10.33024/mnj.v7i1.16315.

Full text
Abstract:
ABSTRACT Benign Prostatic Hyperplasia (BPH) is a non-life-threatening condition that significantly impacts the quality of life of affected individuals. Patients with BPH commonly experience symptoms such as nocturia, increased frequency and urgency of urination, decreased urine flow rate, incomplete bladder emptying, and hesitancy to urinate (Lower Urinary Tract Symptoms/LUTS). LUTS directly impairs the quality of life of BPH patients and contributes to morbidity. The severity of LUTS in BPH patients can be subjectively assessed using the International Prostate Symptom Score (IPSS). This study
APA, Harvard, Vancouver, ISO, and other styles
2

McCONNELL, JOHN D. "The Pathophysiology of Benign Prostatic Hyperplasia." Journal of Andrology 12, no. 6 (1991): 356–63. http://dx.doi.org/10.1002/j.1939-4640.1991.tb00272.x.

Full text
Abstract:
AbstractAlthough benign prostatic hyperplasia (BPH) is one of the most common disease processes affecting the aging male, surprisingly little is known about its pathophysiology. Cause‐and‐effect relationships have not been established, despite intense research efforts in the last four or five decades aimed at elucidating the underlying etiology of prostatic growth in older men. Previously held notions that the clinical symptoms of BPH (prostatism) are due simply to a mass‐related increase in urethral resistance are too simplistic. It is now clear that a significant portion of the symptoms are
APA, Harvard, Vancouver, ISO, and other styles
3

Minciullo, Paola Lucia, Antonino Inferrera, Michele Navarra, Gioacchino Calapai, Carlo Magno, and Sebastiano Gangemi. "Oxidative Stress in Benign Prostatic Hyperplasia: A Systematic Review." Urologia Internationalis 94, no. 3 (2014): 249–54. http://dx.doi.org/10.1159/000366210.

Full text
Abstract:
Background: Several parameters including inflammatory mediators, hormones, dietary factors, inflammatory genes, and oxidative stress (OS) have been considered to play a role in the development of benign prostatic hyperplasia (BPH). Prostate tissue damage and OS may lead to compensatory cellular proliferation with resulting hyperplastic growth. Methods: We searched MEDLINE for articles in English published up to March 2014 using the key words ‘oxidative stress', ‘antioxidants' and ‘benign prostatic hyperplasia'. Results: Prostatic inflammation can cause the generation of free radicals. The exte
APA, Harvard, Vancouver, ISO, and other styles
4

Ishchenko, O., A. Badyukov, T. Badyoukova, A. Zebentaev, and A. Valynets. "Heterogeneity of benign prostatic hyperplasia." Immunopathology, Allergology, Infectology 2022 (April 1, 2022): 45–50. http://dx.doi.org/10.14427/jipai.2022.2.45.

Full text
Abstract:
Background. Benign prostatic hyperplasia (BPH) is a histologically determined condition of the male body and is characterized by glandular-stromal multi-focal proliferation originating from the paraurethral and (or) transition zone of the prostate gland. Proliferative processes in the body are under the control of the immune system. Identifying and understanding the immunological aspects of prostatic hyperplasia can help control prostate tissue growth, improving men's quality of life. The aim of our study was to conduct a pilot study, assessment of the immune status of patients with benign pro
APA, Harvard, Vancouver, ISO, and other styles
5

Sapta Putra, Steven. "THE EFFICACY AND SAFETY OF SILODOSIN FOR THE TREATMENT OF BENIGN HYPERPLASIA PROSTATE: A SYSTEMATIC REVIEW." Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425) 9, no. 10 (2023): 48–52. http://dx.doi.org/10.53555/1wngd289.

Full text
Abstract:
Background: BPH is a prevalent and costly condition affecting the quality of life for older men. adrenoceptor antagonists provide effective relief for bothersome symptoms but do not prevent the need for surgery or acute urinary obstruction. Silodosin, newer adrenoceptor antagonist, offers comparable symptom relief to tamulosin Aim: This systematic review evaluates the efficacy and safety of silodosin for the treatment of benign prostatic hyperplasia (BPH) and its suitability for daily clinical practice.. Methods: This systematic review examined the use of silodosin in men with benign prostatic
APA, Harvard, Vancouver, ISO, and other styles
6

Hasan, Ifrah, Saba Fatima Naqvi, Amraa Khan, Yamna Hasan, and Mir UzairUllah. "A Short Scale Trial to Study and Evaluate the Safety and Efficacy of a Herbal Composition; Verona Anti-BPH Capsule to Treat Benign Prostatic Hyperplasia in Men Older than 40 Years of Age." Current Traditional Medicine 6, no. 4 (2020): 388–94. http://dx.doi.org/10.2174/2215083806666200127090140.

Full text
Abstract:
Aims and objective: Benign Prostatic Hyperplasia (BPH) is a condition that causes the proliferation of the cells of the prostate causing urine retention, renal insufficiency, bladder calculi, recurrent Lower Urinary Tract Infections (LUTS) and in complicated cases, hematuria with unbearable pain. The trial was conducted to study the safety and efficacy of novel herbal product Verona anti- BPH capsules at a local clinic of Sharafi Goth, Karachi Pakistan. Introduction: Benign Prostatic Hyperplasia (BPH) is one major condition. The prevalence of the disease increases to around 8-60% in men at the
APA, Harvard, Vancouver, ISO, and other styles
7

Shahzad, Iqbal, Muhammad Ali Yousuf, Khadim Hussain, Mumtaz Manzoor, Ghulam Mustafa Pathan, and Tanveer Ahmed. "Prostatic Inflammation's Effects on Individuals with Benign Prostate Hyperplasia's Clinical Consequences." Pakistan Journal of Medical and Health Sciences 16, no. 12 (2022): 845–47. http://dx.doi.org/10.53350/pjmhs20221611845.

Full text
Abstract:
Objective: In order to ascertain the impact of silent inflammatory prostatitis on the clinical results of individuals receiving trans urethral prostate resection owing to benign prostatic hyperplasia. Study Design: Retrospective study Place and Duration: This retrospective study was conducted at Liaquat National Hospital Karachi in the period from April, 2022 to September, 2022. Methods: Total 330 patients were presented in this study. In this study, individuals over 45 years without a history of urologic surgery who presented to a urology clinic with lower urinary tract symptoms related to be
APA, Harvard, Vancouver, ISO, and other styles
8

Shahzad, Iqbal, Muhammad Ali Yousuf, Khadim Hussain, Mumtaz Manzoor, Ghulam Mustafa Pathan, and Tanveer Ahmed. "Prostatic Inflammation's Effects on Individuals with Benign Prostate Hyperplasia's Clinical Consequences." Pakistan Journal of Medical and Health Sciences 16, no. 12 (2022): 807–9. http://dx.doi.org/10.53350/pjmhs20221612807.

Full text
Abstract:
Objective: In order to ascertain the impact of silent inflammatory prostatitis on the clinical results of individuals receiving trans urethral prostate resection owing to benign prostatic hyperplasia. Study Design: Retrospective study Place and Duration: This retrospective study was conducted at Liaquat National Hospital Karachi in the period from April, 2022 to September, 2022. Methods: Total 330 patients were presented in this study. In this study, individuals over 45 years without a history of urologic surgery who presented to a urology clinic with lower urinary tract symptoms related to be
APA, Harvard, Vancouver, ISO, and other styles
9

Radhi, Ghazwan Mohammed, Nihad N. Hilal, and ohammed M. Abdul Aziz. "Relationship between PSA and Serum Zinc in BPH-Afflicted Iraqi Men." South Asian Research Journal of Pharmaceutical Sciences 5, no. 04 (2023): 158–67. http://dx.doi.org/10.36346/sarjps.2023.v05i04.009.

Full text
Abstract:
Background: Benign prostatic hyperplasia (BPH) is a common benign tumor of the prostate that becomes more common as men age. The enlarged prostate may compress the urinary tube (urethra), which runs through the middle of the prostate, preventing urine from flowing from the bladder to the outside. Complete obstruction can develop if BPH is severe enough. BPH usually appears after the age of 40 and progresses slowly. Aim of the Study: Studying the connections between serum zinc and PSA in Iraqi BPH patients is the aim of this investigation. Patients and Methods: The case-control study lasted thr
APA, Harvard, Vancouver, ISO, and other styles
10

Zattoni, Fabio, Vincenzo Ficarra, and Giacomo Novara. "Risk Stratification for Benign Prostatic Hyperplasia." Urologia Journal 84, no. 3 (2017): 153–57. http://dx.doi.org/10.5301/uro.5000220.

Full text
Abstract:
Benign prostatic hyperplasia (BPH) represents an important public health problem in ageing men due to frequently associated lower urinary tract symptoms (LUTS), which may impair quality of life. BPH is also a progressive disease, mainly characterized by a worsening of LUTS over time, and in some patients by the occurrence of serious outcomes such as acute urinary retention and need for BPH-related surgery. The management of BPH and LUTS in men should move forward its focus on symptom control only. Indeed, the goals of therapy for BPH are not only to improve bothersome LUTS but also to identify
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "BPH- Benign prostatic hyperplasia"

1

Hatfield, Meghan. "PROSTASIN IS EXPRESSED IN BENIGN PROSTATIC HYPERPLASIA AND REGULATES CELL PROLIFERATION AND INVASION VIA INOS, ICAM-1, AND CYCLI." Master's thesis, University of Central Florida, 2008. http://digital.library.ucf.edu/cdm/ref/collection/ETD/id/4260.

Full text
Abstract:
ABSTRACT Prostasin is expressed in normal prostate epithelial cells but down-regulated in prostate cancers, while prostasin re-expression in invasive prostate cancer cells reduced invasion. We examined prostasin expression and function in benign prostatic hyperplasia (BPH). We evaluated prostasin expression in 12 BPH specimens by immunohistochemistry, and evaluated the impact of prostasin silencing by siRNA on the expression of the inducible nitric oxide synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1), and cyclin D1, as well as on cell proliferation and invasion, using the BPH-1 hu
APA, Harvard, Vancouver, ISO, and other styles
2

Msiska, Thomson. "An in vitro investigation of the effects of camellia sinensis and aspalathus linearis on benign (RPWE 1) and malignant (LNCaP) prostate cell lines." University of the Western Cape, 2015. http://hdl.handle.net/11394/5335.

Full text
Abstract:
Magister Scientiae (Medical Bioscience) - MSc(MBS)<br>The prostate is prone to three pathological processes that include inflammation, benign prostate hyperplasia (BPH) and tumors. According to the center for Disease and Control 1999-2012 report, prostate cancer is the second leading cause of death in the United States. Scientific evidence suggests that up to 30% of men in the general population aged from 50 years and above, irrespective of geographic origin, have foci of prostate neoplastic growth. Unbalanced ROS production and a dysregulated antioxidant defence system have been implicated in
APA, Harvard, Vancouver, ISO, and other styles
3

Jia, Guang. "MR imaging biomarkers for benign prostatic hyperplasia pharmacotherapy." Columbus, Ohio : Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1164686290.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ambrosini, Gina L. "Dietary risk factors for prostate cancer and benign prostatic hyperplasia." University of Western Australia. School of Population Health, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0135.

Full text
Abstract:
[Truncated abstract] This thesis examines the potential role of dietary intake in the development of two common conditions affecting the prostate gland; prostate cancer and benign prostatic hyperplasia (BPH). Diet is of interest as a potential risk factor for prostate cancer because of geographical variations in prostate cancer incidence and increased prostate cancer risks associated with migration from Asian to western countries. Some geographical variation has been suggested for BPH, but this is less certain. However, both prostate cancer and BPH have potential links with diet through their
APA, Harvard, Vancouver, ISO, and other styles
5

Fernandes, Ancilla W. "Evaluating diagnostic and treatment modalities in the management of benign prostatic hyperplasia in the Veterans Administration population." Morgantown, W. Va. : [West Virginia University Libraries], 2000. http://etd.wvu.edu/templates/showETD.cfm?recnum=1543.

Full text
Abstract:
Thesis (M.S.)--West Virginia University, 2000.<br>Title from document title page. Document formatted into pages; contains ix, 154 p. : ill. Includes abstract. Includes bibliographical references (p. 137-143).
APA, Harvard, Vancouver, ISO, and other styles
6

Chan, Hin-cheong. "The psychometric evaluation of the Chinese version of the international prostate symptom score (IPSS)." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31972871.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Noble, Amanda Jane. "The alpha←1-andrenoceptor subtype mediating contraction of the lower urinary tract." Thesis, University of Sheffield, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.284384.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Xu, Kexin. "Identification and evaluation of specific marker proteins associated with human benign peostate [sic] hyperplasia /." Hong Kong : University of Hong Kong, 2002. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25435863.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hallin, Anders. "Transurethral microwave thermotherapy of benign prostatic hyperplasia : a clinical and methodological evaluation /." Stockholm, 1997. http://diss.kib.ki.se/1997/91-628-2727-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Woo, Henry Hyunshik. "Evolution of minimally invasive surgical treatments for benign prostatic obstruction." Thesis, The University of Sydney, 2016. http://hdl.handle.net/2123/15772.

Full text
Abstract:
Transurethral resection of the prostate (TURP) has been the established surgical gold standard for the treatment of prostatic obstruction due to benign prostatic hyperplasia(BPH). Prior to TURP, the mainstay of surgical treatment was open suprapubic prostatectomy (SPP), which carried a high risk of morbidity and mortality. TURP did not go through rigorous assessment of outcomes or comparison with SPP in order to become labeled as the gold standard. TURP is still a procedure with potential significant morbidity, particular with regard to hemorrhage and surgical misadventure. In the mid to
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "BPH- Benign prostatic hyperplasia"

1

International Consultation on Benign Prostatic Hyperplasia (5th 2000 Paris, France). Benign prostatic hyperplasia: 5th International Consultation on Benign Prostatic Hyperplasia (BPH), June 25-28, 2000, Paris. Edited by Chatelain C, World Health Organization, and International Union against Cancer. Health Publication, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

H, Kurth Karl, Newling Donald W. W, and Dutch Urological Association. International Congress, eds. Benign prostatic hyperplasia: Recent progress in clinicalresearch and practice : based on the proceedings of the Second International Congress of the Dutch Urological Association, "New Insights Into the Aetiology, Diagnosis, and Management of BPH," held in Amsterdam, November 4-6, 1993. Wiley-Liss, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Petrovich, Zbigniew, and Luc Baert, eds. Benign Prostatic Hyperplasia. Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-78185-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jakse, Gerhard, Christian Bouffioux, Jean de Leval, and Rudi A. Janknegt, eds. Benign Prostatic Hyperplasia. Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-77480-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kirby, Roger S. Benign prostatic hyperplasia. Gower Medical, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

J, Christmas Timothy, ed. Benign prostatic hyperplasia. Gower Medical Publishing, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

International Consultation on Benign Prostatic Hyperplasia (5th 2000 Paris, France). Benign prostatic hyperplasia. Edited by Chatelain C. (Chritian), World Health Organization, and International Union against Cancer. Health Publication, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Physicians, American College of, and Hearst/ABC Viacom, eds. Benign prostatic hyperplasia. Burrells's [distributor], 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Koshiba, Ken, Makoto Miki, Toshiro Terachi, and Toyoaki Uchida, eds. Treatment of Benign Prostatic Hyperplasia. Springer Japan, 2000. http://dx.doi.org/10.1007/978-4-431-68444-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

D, Chisholm Geoffrey, ed. Handbook on benign prostatic hyperplasia. Raven Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "BPH- Benign prostatic hyperplasia"

1

De Nunzio, Cosimo, Riccardo Lombardo, Antonio Maria Cicione, and Andrea Tubaro. "Benign Prostatic Hyperplasia (BPH)." In Urologic Principles and Practice. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-28599-9_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tubaro, Andrea, and Cosimo de Nunzio. "Benign Prostatic Hyperplasia (BPH)." In Practical Urology: Essential Principles and Practice. Springer London, 2011. http://dx.doi.org/10.1007/978-1-84882-034-0_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

McNicholas, Tom. "Benign Prostatic Hyperplasia (BPH)." In Men's Health. CRC Press, 2021. http://dx.doi.org/10.1201/9780429347238-13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Giannakis, Ioannis, Thomas R. W. Herrmann, and Thorsten Bach. "Benign Prostatic Hyperplasia (BPH)." In Urologic Surgery in the Digital Era. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63948-8_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Laduc, R. "Transurethrale Microwave Thermotherapy (TUMT) in Patients with Benign Prostatic Hyperplasia (BPH)." In Benign Prostatic Hyperplasia. Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-77480-5_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Krieg, Michael, and Sabine Tunn. "Androgens and human benign prostatic hyperplasia (BPH)." In Testosterone. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-662-00814-0_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Abboudi, Hamid, Jas S. Kalsi, and Tev Aho. "Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS)." In MCQs for the FRCS(Urol) and Postgraduate Urology Examinations. CRC Press, 2020. http://dx.doi.org/10.1201/9780429021633-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

DuBeau, Catherine E. "Benign Prostatic Hyperplasia." In Geriatric Medicine. Springer New York, 1997. http://dx.doi.org/10.1007/978-1-4757-2705-0_37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sotelo, René, Raed A. Azhar, and José Luis Gaona Morales. "Benign Prostatic Hyperplasia." In Prostate Cancer. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-05600-5_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Te, Alexis E., and Bilal Chughtai. "Benign Prostatic Hyperplasia." In Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118437889.ch16.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "BPH- Benign prostatic hyperplasia"

1

Hamel, Kory P. "Technology advancements in the treatment of benign prostatic hyperplasia." In Advanced Photonics in Urology 2025, edited by Hyun Wook Kang, Ronald Sroka, and Jian J. Zhang. SPIE, 2025. https://doi.org/10.1117/12.3050305.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Vaks, Vladimir, Mariya Chernyaeva, Vagif Atduev, et al. "Analysis of Thermal Decomposition Products of Urine at Prostate Cancer and Benign Prostatic Hyperplasia by Terahertz High-Resolution Gas Spectroscopy." In 2024 IEEE 9th All-Russian Microwave Conference (RMC). IEEE, 2024. https://doi.org/10.1109/rmc62880.2024.10846830.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Valvano, Jonathan W., David Y. Yuan, Eric N. Rudie, and Steven J. Clark. "Treatment of Benign Prostatic Hyperplasia." In ASME 1996 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1996. http://dx.doi.org/10.1115/imece1996-0741.

Full text
Abstract:
Abstract The treatment of benign prostatic hyperplasia (BPH) has implications which affect the majority of the adult male population. Although benign compared to prostate cancer, clinical symptoms can dramatically alter the quality of life. The hyperplastic tissue can cause constriction of the urethra and thus affect voiding of urine. Factors to consider for thermally-based treatments of the prostate include minimization of thermal injury to the urethra and rectum, and maximal delivery of thermal energy to target tissue. Minimizing temperature rise in the urethra allows for minimal or no anest
APA, Harvard, Vancouver, ISO, and other styles
4

Thamire, Chandrasekhar, and Sharath Bellary. "A Numerical Study of Microwave Thermotherapy for Benign Prostatic Hyperplasia." In ASME 2003 Heat Transfer Summer Conference. ASMEDC, 2003. http://dx.doi.org/10.1115/ht2003-47505.

Full text
Abstract:
Transurethral resection of the prostate is the conventional therapy used for relieving bladder-outflow obstruction that typically occurs in older men due to benign prostatic hyperplasia (BPH). Due to the complications and side effects involved, other therapies that are less invasive have been in use over the last few years. The current study examines one such therapy, namely, the transurethral thermal therapy, and its effectiveness as a treatment modality for BPH. The system considered here is capable of delivering microwave energy preferentially into the prostatic tissue. The heat generated i
APA, Harvard, Vancouver, ISO, and other styles
5

Chinn, Daniel, Elvis Nditafon, Alvin Yew, and Chandrasekhar Thamire. "Thermal Therapy Protocols for Benign Prostatic Hyperplasia." In ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-176764.

Full text
Abstract:
Thermal therapy for treatment of benign prostatic hyperplasia (BPH) is becoming increasingly popular due to the minimally invasive nature of the treatment. Successful management of such therapy requires accurate estimation of thermal dosage. The purpose of this study is to provide correlations for the thermal damage caused by ultrasound, microwave, and infrared devices under a range of operating conditions. A boundary-fitting finite difference method is used to examine the heat transfer in the prostate gland and surrounding tissue. The Pennes bioheat transfer model and a porous media model wer
APA, Harvard, Vancouver, ISO, and other styles
6

Brooks, Lucy. "An introduction to prostatic artery embolisation (PAE) and benign prostatic hyperplasia (BPH)." In Radiopaedia 2025 Virtual Conference. Radiopaedia.org, 2025. https://doi.org/10.53347/rposter-3159.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Thamire, Chandrasekhar, Rabee Zuberi, Charlie Choe, and Prabhakar Pandey. "Treatment Planning for Transurethral and Interstitial Thermal Therapy for Benign Prostatic Hyperplasia." In ASME 2009 International Mechanical Engineering Congress and Exposition. ASMEDC, 2009. http://dx.doi.org/10.1115/imece2009-10903.

Full text
Abstract:
The purpose of this study is to develop thermal-damage correlations for transurethral and interstitial thermotherapy to aid treatment planning for benign prostatic hyperplasia (BPH). Using an Alternating-direction implicit method, the Pennes bioheat transfer equation is solved for microwave and ultrasound hyperthermia applicators for a range of parameters, including the applicator power, treatment time, and coolant parameters. Thermal coagulation contours are developed by evaluating the temperature-history data against the thermal-damage data obtained in ex-vivo experiments for prostate tissue
APA, Harvard, Vancouver, ISO, and other styles
8

Paolini, Lara, and Chandrasekhar Thamire. "Treatment Protocols for Managing Transurethral Thermal Therapy for Benign Prostatic Hyperplasia." In ASME 2005 International Mechanical Engineering Congress and Exposition. ASMEDC, 2005. http://dx.doi.org/10.1115/imece2005-81421.

Full text
Abstract:
Application of thermal therapy using microwave or ultrasound applicators is becoming increasingly popular as a minimally invasive treatment for benign prostatic hyperplasia (BPH). Successful management of the therapy using such methods requires an accurate estimation of the thermal dosage. The purpose of this study is to theoretically evaluate the thermal damage caused by different heating sources for different values of thermal doses and operating parameters. Using a 3-D finite differences method, the Pennes bio-heat transfer equation is solved for selected operating parameters. Necrosis zone
APA, Harvard, Vancouver, ISO, and other styles
9

Bhowmick, Sankha, Pragati Bhowmick, James E. Coad, and John C. Bischof. "In Vitro Assessment of the Efficacy of Thermal Therapy in Human Benign Prostatic Hyperplasia Tissue." In ASME 2001 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2001. http://dx.doi.org/10.1115/imece2001/htd-24434.

Full text
Abstract:
Abstract Correlation between thermal history and tissue destruction is of considerable importance for successful management of BPH using minimally invasive thermal therapies such as radiofrequency or microwave probes. In order to accomplish this goal, the present in vitro study assesses the cellular viability of BPH tissue subjected to different temperature-times in an experimental matrix. Hyperplastic prostatic tissue was obtained from 8 patients after the surgical removal of the glands for other reasons (typically cancer). A piece of tissue was taken from the lateral lobe of the gland and wa
APA, Harvard, Vancouver, ISO, and other styles
10

de Riese, Werner T., Brent A. Sharpe, David B. Aronoff, and Bernhard T. Mittemeyer. "Role of laser therapy in benign prostate hyperplasia (BPH)." In BiOS 2001 The International Symposium on Biomedical Optics, edited by R. Rox Anderson, Kenneth E. Bartels, Lawrence S. Bass, et al. SPIE, 2001. http://dx.doi.org/10.1117/12.427807.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "BPH- Benign prostatic hyperplasia"

1

Sciacqua, Lucilla Violetta, Andrea Vanzulli, Rosario Di Meo, et al. Minimally invasive treatment in Benign Prostatic Hyperplasia (BPH). INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0004.

Full text
Abstract:
Condition being studied: Review efficacy and safety of minimally-invasive treatments for Low Urinary Tract Symptoms (LUTS) in patients affected by Benign Prostate Hyperplasia (BPH). These minimally invasive techniques represent a valid alternative for patients who can no longer continue medical therapy or are ineligible to surgery. Eligibility criteria: The inclusion criteria concern the most relevant clinical trials on minimally invasive interventions for Benign Prostatic Hyperplasia (BPH) from January 1993 to January 2022.
APA, Harvard, Vancouver, ISO, and other styles
2

Gradinarska, Desislava, Maria Ivanova, Miroslav Genov, Tsvetan Tsvetkov, and Denica Daskalova. Comparative Assay of Seminal-plasma Proteins in Healthy Dogs and Dogs with Benign Prostatic Hyperplasia. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2019. http://dx.doi.org/10.7546/crabs.2019.08.17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wang, Jiaze, Tingting Deng, Hao Sun, et al. Efficacy and safety of moxisibostion for benign prostatic hyperplasia: a protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.12.0021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chen, Feng, Yijin Chen, Yongsheng Zou, Yunxiao Wang, Xiaogang Wu, and Milian Chen. Comparison of holmium laser enucleation of prostate and transurethral resection of prostate in patients with benign prostatic hyperplasia: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.5.0065.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zhang, Xiaolong, Huali Xu, Zhirong Zhu, and Guiliang Tang. The worldwide incidence of bladder neck contracture after transurethral surgery of prostate by thulium laser for benign prostatic hyperplasia: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.4.0007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'BPH- Benign prostatic hyperplasia' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography